Invited speakers and chairs
<alphabetical order by surname>
(*) denotes the role of Chair
Philippe L. Bedard
University Health Network and Princess Margaret Cancer Centre, Canada
Session 1: Genome Data Science/
*Session 7: Cancer Progression and Treatment Development
(Session 1)
AACR Project GENIE: Global Data Sharing and Real-World Evidence in Precision Oncology
Francesca deMichelis
University of Trento, Italy
*Session 1: Genome Data Science/
Session 7: Cancer Progression and Treatment Development
(Session 7)
The Space of Germline-somatic Interactions in Precision Medicine
Toshihiko Doi
National Cancer Center Hospital East, Japan
Irene M. Ghobrial
Dana-Farber Cancer Institute, US
Session 2: Hematologic Malignancies /
*Session 3: Clonal Hematopoiesis / Tumor microenvironment
(Session 2)
Monoclonal Gammopathy of Undetermined Significance (MGUS) and Smoldering Multiple Myeloma (SMM)
Susumu Goyama
The University of Tokyo, Japan
Session 2: Hematologic Malignancies
RNA Targeting with CRISPR/Cas13 for Next-generation Precision Medicine
Motohiro Kato
The University of Tokyo, Japan
Keynote /
*Session 4: Pediatric Cancer /
*Session 8: Unravelling genome complexity
(Keynote)
Refining Maintenance Therapy in Acute Lymphoblastic Leukemia: Toward More Personalized Approaches
Shota Kato
The University of Tokyo, Japan
Rapid and Comprehensive Molecular Profiling of Pediatric Cancers using Nanopore Sequencer
Jeffery M. Klco
St. Jude Children's Research Hospital, US
Pediatric Myeloid Neoplasms: New entities and Diagnostic Strategies
Takashi Kohno
National Cancer Center Research Institute, Japan
*Session 1: Genome Data Science
Insights from Real-World Data on 100,000 Patients with Advanced Cancer: Japan’s Nationwide Clinicogenomic C-CAT Database
Mikhail Kolmogorov
National Cancer Institute,US
Stadman Investigator
Session 8: Unravelling genome complexity
Detection of Somatic Structural Variation and Complex Rearrangements in Cancer Genomes Using Long-Read Sequencing
Takashi Kojima
National Cancer Center Hospital East, Japan
Session 6: Cancer Immunotherapy
The Relationship of Immune Checkpoint Inhibitors with Radiotherapy: Translational Research from the TENERGY Study.
Shohei Koyama
National Cancer Center Research Institute, Japan
Session 5: Cancer Immunotherapy /
Session 6: Cancer Immunotherapy (Round table discussion)
(Session 5)
Identifying Mechanisms for Augmenting Antitumour Efficacy of PD-1 Blockade by Gut Microbiota
Hiroyuki Mano
National Cancer Center Research Institute, Japan
Hiroyoshi Nishikawa
Kyoto University, Japan
Session 5: Cancer Immunotherapy /
*Session 6: Cancer Immunotherapy (Round table discussion)
(Session 5)
Immuno-genomic Analysis Elucidates Immunosuppressive Mechanisms in the Tumor Microenvironment
Emi Nishimura
The University of Tokyo, Japan
*Session 7: Cancer progression and treatment development
(Session 7)
How Stem Cells Age and Evolve into Cancer: Insights from the Skin
Yotaro Ochi
Kyoto University, Japan
Session 2: Hematologic Malignancies
Epigenetic Heterogeneity of Leukemia
Daisuke Okajima
Daiichi Sankyo, Inc., Japan
Session 7: Cancer progression and treatment development
An Overview of the DXd-ADC Technology Platform and the Latest Clinical Results
Mamiko Sakata-Yanagimoto
Tsukuba University, Japan
* Session 3: Clonal Hematopoiesis / Tumor microenvironment
Unraveling the Ecosystem of Follicular Lymphoma
Aldo Scarpa
University of Verona, Italy
Session 8: Unravelling genome complexity
Unravelling the Complexity of Pancreatic Neoplasms
Yuichi Shiraishi
National Cancer Center Research Institute, Japan
Session 8: Unravelling genome complexity
Centromeric Variation and Its Impact on Chromosomal Rearrangements in Cancer
Peter K. Sorger
Harvard University, US
*Session 6: Cancer Immunotherapy (Round table discussion)
Spatial Profiling of the Melanoma Microenvironment to Improve Diagnosis and Risk Assessment
Christian Steidl
British Columbia Cancer Research Centre, Canada
Session 3: Clonal Hematopoiesis / Tumor microenvironment
Multidimensional Characterization of Cellular Ecosystems in Hodgkin Lymphoma
Hiromichi Suzuki
National Cancer Center Research Institute, Japan
Advancing the Molecular Understanding of Medulloblastoma through Genomic Insights into Subgroup-Specific Mechanisms and Origins
Junko Takita
Kyoto University, Japan
Yosuke Togashi
Okayama University, Japan
Marcel R.M. van den Brink
City of Hope National Medical Center, US
*Session 5: Cancer Immunotherapy /
Session 6: Cancer Immunotherapy (Round table discussion)
The Role of The Intestinal Microbiome in Cancer Immunotherapy
(Session 5)
The Role of The Intestinal Microbiome in Cancer Immunotherapy
Victor E. Velculescu
Johns Hopkins University, US
Keynote/*Session 8:Unravelling Genome Complexity
(Keynote)
Genomic and Fragmentomic Landscapes of Cell-free DNA for Early Cancer Detection
Kenichi Yoshida
National Cancer Center Research Institute, Japan
Session 7: Cancer progression and treatment development
Whole-Genome Sequencing of Upper Urinary Tract Urothelial Carcinomas
Caitlin C. Zebley
St. Jude Children's Research Hospital, US
*Session 2: Hematologic Malignancies/
Session 3: Clonal Hematopoiesis / Tumor microenvironment
(Session 3)
A Reverse Translation
Approach to Advance T Cell Immunotherapies
Wei Zhou
Massachusetts General Hospital and Harvard Medical School, US
Session 1: Genome Data Science
Biobank/Cohort-scale Human Genetics and Functional Genomics